Understanding Antipsychotic Medications in Nursing Homes

Antipsychotic medications are commonly used in long-term care facilities to manage symptoms of schizophrenia, bipolar disorder, and severe behavioral disturbances.However, their use in nursing homes—particularly for residents with dementia—has come under increased scrutiny. While these medications can be beneficial in certain cases, they also pose significant risks and must be used responsibly to ensure resident safety and compliance with regulatory standards.

In this blog, we’ll break down:

1. The types of antipsychotic medications
2. Their intended use vs. off-label use in nursing homes
3. The risks associated with their use
4. Best practices for responsible prescribing

Additionally, we’ll discuss how Qsource, Nursing Home Consultants,  supports nursing homes in implementing safe medication practices and reducing unnecessary antipsychotic use.

What Are Antipsychotic Medications?

Antipsychotics are a class of medications designed to alter brain chemistry to manage psychiatric conditions. They work by affecting dopamine and serotonin receptors, which play a role in mood, perception, and behavior regulation.

Types of Antipsychotic Medications

Antipsychotics fall into two main categories:

1. Typical Antipsychotics (First-Generation)
   1. Developed in the 1950s
   2. Strong dopamine-blocking properties
   3. Higher risk of extrapyramidal symptoms (involuntary muscle movements)
   4. Examples: Haloperidol (Haldol), Chlorpromazine (Thorazine)
2. Atypical Antipsychotics (Second-Generation)
   1. Introduced in the 1990s
   2. Block dopamine and serotonin receptors
   3. Lower risk of extrapyramidal symptoms but higher risk of metabolic side effects
   4. Examples: Risperidone (Risperdal), Olanzapine (Zyprexa), Quetiapine (Seroquel)

Learn about Our Consulting Services

Why Are Antipsychotics Used in Nursing Homes?

In some cases, antipsychotics are necessary for residents with diagnosed psychiatric disorders such as schizophrenia or bipolar disorder. However, these medications are frequently prescribed off-label to manage behavioral symptoms of dementia, including:

• Agitation
• Aggression
• Hallucinations or delusions
• Restlessness or wandering

While these behaviors can be challenging for staff to manage, antipsychotics are not always the best solution and should only be used when clinically justified.

According to the Centers for Medicare & Medicaid Services (CMS), antipsychotics should not be the first-line treatment for dementia-related behaviors due to the serious health risks they pose. Instead, non-pharmacological interventions should be prioritized before considering medication. 

The Risks of Antipsychotic Use in Elderly Populations

The FDA has issued black box warnings against using antipsychotics in elderly patients with dementia due to an increased risk of death. Other serious risks include:

1. Increased Mortality Risk – Studies show that elderly patients with dementia who take antipsychotics have a higher risk of fatal cardiovascular events such as strokes and heart attacks.
2. Sedation and Cognitive Decline – Many residents experience excessive drowsiness, making them less engaged and more withdrawn.
3. Higher Fall and Fracture Risk – Antipsychotics impair balance and coordination, leading to more frequent and severe falls.
4. Aspiration Pneumonia Risk – Sedation increases the likelihood of swallowing difficulties, leading to pneumonia.
5. Metabolic Issues – Long-term use is linked to diabetes, weight gain, and increased cholesterol levels.

Because of these risks, nursing homes must carefully assess the necessity of antipsychotics and seek alternative approaches whenever possible.

Best Practices for Responsible Antipsychotic Use in Nursing Homes

To ensure resident safety and regulatory compliance, facilities should follow best practices when considering antipsychotic treatment:

1. Behavioral approaches (e.g., redirecting attention, music therapy)
2. Environmental modifications (e.g., reducing noise, improving lighting)
3. Routine-based interventions (e.g., structured activities, calming techniques)

1. Antipsychotics should be limited to residents with severe psychiatric symptoms or behaviors that pose a danger to themselves or others.
2. Medication use should be time-limited, with frequent reassessments.

1. Families and residents (when capable) should be fully informed of the risks and must give written consent before medication is administered.
2. The facility should document all non-drug interventions attempted before prescribing an antipsychotic.

• CMS requires that facilities attempt to reduce or discontinue antipsychotics at regular intervals unless clinically contraindicated.

Organizations like Qsource provide education, resources, and consulting services to help nursing homes:

• Implement best practices for reducing unnecessary medication use
• Conduct medication audits to identify areas for improvement
• Train staff on alternative interventions and compliance

By working with Qsource, facilities can improve patient outcomes while maintaining regulatory compliance and improving their CMS quality ratings.

Book a Free Consultation

Qsource’s Role in Antipsychotic Reduction Initiatives

Qsource plays a crucial role in helping nursing homes reduce inappropriate medication use through:

• Clinical Training for Staff – Teaching teams how to manage behaviors without medications
• Data Analysis & Benchmarking – Helping facilities track and improve their antipsychotic reduction goals
• Regulatory Compliance Support – Ensuring adherence to CMS guidelines and survey readiness

Understanding antipsychotic medications is crucial for nursing home staff and administrators. While these medications have their place in psychiatric care, they must be used with caution in elderly populations due to severe risks.

By prioritizing non-drug interventions, obtaining proper consent, and following CMS regulations, facilities can improve resident safety while avoiding regulatory citations. Partnering with organizations like Qsource can provide essential training and support to help nursing homes reduce unnecessary antipsychotic use and promote better care outcomes.